1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Binge Eating Disorder Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global Binge Eating Disorder Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antidepressants
1.4.3 Anticonvulsants
1.4.4 Anti-obesity Medications
1.5 Market by Application
1.5.1 Global Binge Eating Disorder Drug Market Share by Application: 2021-2026
1.5.2 Retail Pharmacies
1.5.3 Hospital Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Binge Eating Disorder Drug Market
1.8.1 Global Binge Eating Disorder Drug Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Binge Eating Disorder Drug Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Binge Eating Disorder Drug Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Binge Eating Disorder Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Binge Eating Disorder Drug Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Binge Eating Disorder Drug Sales Volume Market Share by Region (2015-2020)
3.2 Global Binge Eating Disorder Drug Sales Revenue Market Share by Region (2015-2020)
3.3 North America Binge Eating Disorder Drug Sales Volume
3.3.1 North America Binge Eating Disorder Drug Sales Volume Growth Rate (2015-2020)
3.3.2 North America Binge Eating Disorder Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Binge Eating Disorder Drug Sales Volume
3.4.1 East Asia Binge Eating Disorder Drug Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Binge Eating Disorder Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Binge Eating Disorder Drug Sales Volume (2015-2020)
3.5.1 Europe Binge Eating Disorder Drug Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Binge Eating Disorder Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Binge Eating Disorder Drug Sales Volume (2015-2020)
3.6.1 South Asia Binge Eating Disorder Drug Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Binge Eating Disorder Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Binge Eating Disorder Drug Sales Volume (2015-2020)
3.7.1 Southeast Asia Binge Eating Disorder Drug Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Binge Eating Disorder Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Binge Eating Disorder Drug Sales Volume (2015-2020)
3.8.1 Middle East Binge Eating Disorder Drug Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Binge Eating Disorder Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Binge Eating Disorder Drug Sales Volume (2015-2020)
3.9.1 Africa Binge Eating Disorder Drug Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Binge Eating Disorder Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Binge Eating Disorder Drug Sales Volume (2015-2020)
3.10.1 Oceania Binge Eating Disorder Drug Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Binge Eating Disorder Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Binge Eating Disorder Drug Sales Volume (2015-2020)
3.11.1 South America Binge Eating Disorder Drug Sales Volume Growth Rate (2015-2020)
3.11.2 South America Binge Eating Disorder Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Binge Eating Disorder Drug Sales Volume (2015-2020)
3.12.1 Rest of the World Binge Eating Disorder Drug Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Binge Eating Disorder Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Binge Eating Disorder Drug Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Binge Eating Disorder Drug Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Binge Eating Disorder Drug Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Binge Eating Disorder Drug Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Binge Eating Disorder Drug Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Binge Eating Disorder Drug Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Binge Eating Disorder Drug Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Binge Eating Disorder Drug Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Binge Eating Disorder Drug Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Binge Eating Disorder Drug Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Binge Eating Disorder Drug Sales Volume Market Share by Type (2015-2020)
14.2 Global Binge Eating Disorder Drug Sales Revenue Market Share by Type (2015-2020)
14.3 Global Binge Eating Disorder Drug Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Binge Eating Disorder Drug Consumption Volume by Application (2015-2020)
15.2 Global Binge Eating Disorder Drug Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Binge Eating Disorder Drug Business
16.1 Roche
16.1.1 Roche Company Profile
16.1.2 Roche Binge Eating Disorder Drug Product Specification
16.1.3 Roche Binge Eating Disorder Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Novo Nordisk
16.2.1 Novo Nordisk Company Profile
16.2.2 Novo Nordisk Binge Eating Disorder Drug Product Specification
16.2.3 Novo Nordisk Binge Eating Disorder Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Chronos Therapeutics
16.3.1 Chronos Therapeutics Company Profile
16.3.2 Chronos Therapeutics Binge Eating Disorder Drug Product Specification
16.3.3 Chronos Therapeutics Binge Eating Disorder Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Opiant Pharmaceuticals
16.4.1 Opiant Pharmaceuticals Company Profile
16.4.2 Opiant Pharmaceuticals Binge Eating Disorder Drug Product Specification
16.4.3 Opiant Pharmaceuticals Binge Eating Disorder Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Heptares
16.5.1 Heptares Company Profile
16.5.2 Heptares Binge Eating Disorder Drug Product Specification
16.5.3 Heptares Binge Eating Disorder Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Sunovion Pharmaceuticals
16.6.1 Sunovion Pharmaceuticals Company Profile
16.6.2 Sunovion Pharmaceuticals Binge Eating Disorder Drug Product Specification
16.6.3 Sunovion Pharmaceuticals Binge Eating Disorder Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Omeros Corp
16.7.1 Omeros Corp Company Profile
16.7.2 Omeros Corp Binge Eating Disorder Drug Product Specification
16.7.3 Omeros Corp Binge Eating Disorder Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Binge Eating Disorder Drug Manufacturing Cost Analysis
17.1 Binge Eating Disorder Drug Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Binge Eating Disorder Drug
17.4 Binge Eating Disorder Drug Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Binge Eating Disorder Drug Distributors List
18.3 Binge Eating Disorder Drug Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Binge Eating Disorder Drug (2021-2026)
20.2 Global Forecasted Revenue of Binge Eating Disorder Drug (2021-2026)
20.3 Global Forecasted Price of Binge Eating Disorder Drug (2015-2026)
20.4 Global Forecasted Production of Binge Eating Disorder Drug by Region (2021-2026)
20.4.1 North America Binge Eating Disorder Drug Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Binge Eating Disorder Drug Production, Revenue Forecast (2021-2026)
20.4.3 Europe Binge Eating Disorder Drug Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Binge Eating Disorder Drug Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Binge Eating Disorder Drug Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Binge Eating Disorder Drug Production, Revenue Forecast (2021-2026)
20.4.7 Africa Binge Eating Disorder Drug Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Binge Eating Disorder Drug Production, Revenue Forecast (2021-2026)
20.4.9 South America Binge Eating Disorder Drug Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Binge Eating Disorder Drug Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Binge Eating Disorder Drug by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Binge Eating Disorder Drug by Country
21.2 East Asia Market Forecasted Consumption of Binge Eating Disorder Drug by Country
21.3 Europe Market Forecasted Consumption of Binge Eating Disorder Drug by Countriy
21.4 South Asia Forecasted Consumption of Binge Eating Disorder Drug by Country
21.5 Southeast Asia Forecasted Consumption of Binge Eating Disorder Drug by Country
21.6 Middle East Forecasted Consumption of Binge Eating Disorder Drug by Country
21.7 Africa Forecasted Consumption of Binge Eating Disorder Drug by Country
21.8 Oceania Forecasted Consumption of Binge Eating Disorder Drug by Country
21.9 South America Forecasted Consumption of Binge Eating Disorder Drug by Country
21.10 Rest of the world Forecasted Consumption of Binge Eating Disorder Drug by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer